- Home
- DERM
as 12-20-2024 4:00pm EST
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | SCOTTSDALE |
| Market Cap: | 116.8M | IPO Year: | 2021 |
| Target Price: | $9.50 | AVG Volume (30 days): | 109.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.85 - $8.10 | Next Earning Date: | 11-12-2024 |
| Revenue: | $57,771,000 | Revenue Growth: | -27.69% |
| Revenue Growth (this year): | -26.93% | Revenue Growth (next year): | 36.49% |
Latest Journey Medical Corporation News
DERM Breaking Stock News: Dive into DERM Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
Despite Journey Medical's Pullback, Insiders Still Gained US$118k
Zacks
a month ago
Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates
GlobeNewswire
a month ago
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Pharmaceutical Technology
2 months ago
FDA approves Journey Medical’s rosacea treatment Emrosi
MT Newswires
2 months ago
Journey Medical Gets FDA Approval for Rosacea Treatment
Zacks
2 months ago
Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?
GlobeNewswire
2 months ago
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
GlobeNewswire
2 months ago
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
Compare DERM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DERM Journey Medical Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.